117 related articles for article (PubMed ID: 8240982)
1. Estrogen and androgen receptor mediated stimulation and inhibition of proliferation by androst-5-ene-3 beta,17 beta-diol in human mammary cancer cells.
Hackenberg R; Turgetto I; Filmer A; Schulz KD
J Steroid Biochem Mol Biol; 1993 Nov; 46(5):597-603. PubMed ID: 8240982
[TBL] [Abstract][Full Text] [Related]
2. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study.
Chen J; Wang WQ; Lin SX
J Steroid Biochem Mol Biol; 2013 Sep; 137():316-21. PubMed ID: 23416106
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids.
Hackenberg R; Schulz KD
J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):113-7. PubMed ID: 8603031
[TBL] [Abstract][Full Text] [Related]
4. Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells.
Miyamoto H; Yeh S; Lardy H; Messing E; Chang C
Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11083-8. PubMed ID: 9736693
[TBL] [Abstract][Full Text] [Related]
5. Estrogenic effects of physiological concentrations of 5-androstene-3 beta, 17 beta-diol and its metabolism in MCF7 human breast cancer cells.
Adams J; Garcia M; Rochefort H
Cancer Res; 1981 Nov; 41(11 Pt 1):4720-6. PubMed ID: 6458355
[TBL] [Abstract][Full Text] [Related]
6. Interactions between estrogens, androgens, progestins, and glucocorticoids in ZR-75-1 human breast cancer cells.
Labrie F; Poulin R; Simard J; Zhao HF; Labrie C; Dauvois S; Dumont M; Hatton AC; Poirier D; Mérand Y
Ann N Y Acad Sci; 1990; 595():130-48. PubMed ID: 2142871
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of cell proliferation and estrogenic response by adrenal C19-delta 5-steroids in the ZR-75-1 human breast cancer cell line.
Poulin R; Labrie F
Cancer Res; 1986 Oct; 46(10):4933-7. PubMed ID: 2944574
[TBL] [Abstract][Full Text] [Related]
8. Suppression of Delta(5)-androstenediol-induced androgen receptor transactivation by selective steroids in human prostate cancer cells.
Chang HC; Miyamoto H; Marwah P; Lardy H; Yeh S; Huang KE; Chang C
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11173-7. PubMed ID: 10500149
[TBL] [Abstract][Full Text] [Related]
9. 5-En-androstene-3 beta,17 beta-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol.
Boccuzzi G; Brignardello E; Di Monaco M; Gatto V; Leonardi L; Pizzini A; Gallo M
Br J Cancer; 1994 Dec; 70(6):1035-9. PubMed ID: 7981051
[TBL] [Abstract][Full Text] [Related]
10. Dehydroepiandrosterone and androst-5-ene-3 beta,17 beta-diol in human mammary cancer cytosolic and nuclear compartments and their relationship to estrogen receptor.
Adams JB; Archibald L; Seymour-Munn K
Cancer Res; 1980 Oct; 40(10):3815-20. PubMed ID: 6449285
[TBL] [Abstract][Full Text] [Related]
11. Interaction of delta-5-androstene-3beta, 17beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue.
Poortman J; Prenen JA; Schwarz F; Thijssen JH
J Clin Endocrinol Metab; 1975 Mar; 40(3):373-9. PubMed ID: 163841
[TBL] [Abstract][Full Text] [Related]
12. Adrenal C19-5-ene steroids induce full estrogenic responses in rat pituitary gonadotrophs.
Simard J; Labrie F
J Steroid Biochem; 1987 May; 26(5):539-46. PubMed ID: 2953941
[TBL] [Abstract][Full Text] [Related]
13. Actions and interactions of delta 5-androstene-3 beta, 17 beta-diol and 17 beta-estradiol in the immature rat uterus.
van Doorn LG; Poortman J; Thijssen JH; Schwarz F
Endocrinology; 1981 Apr; 108(4):1587-93. PubMed ID: 7472285
[TBL] [Abstract][Full Text] [Related]
14. Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism.
Hanamura T; Niwa T; Nishikawa S; Konno H; Gohno T; Tazawa C; Kobayashi Y; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S
Breast Cancer Res Treat; 2013 Jun; 139(3):731-40. PubMed ID: 23780684
[TBL] [Abstract][Full Text] [Related]
15. The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype.
Guerini V; Sau D; Scaccianoce E; Rusmini P; Ciana P; Maggi A; Martini PG; Katzenellenbogen BS; Martini L; Motta M; Poletti A
Cancer Res; 2005 Jun; 65(12):5445-53. PubMed ID: 15958594
[TBL] [Abstract][Full Text] [Related]
16. Androgen-like and anti-androgen-like effects of antiprogestins in human mammary cancer cells.
Hackenberg R; Hannig K; Beck S; Schmidt-Rhode P; Scholz A; Schulz KD
Eur J Cancer; 1996 Apr; 32A(4):696-701. PubMed ID: 8695275
[TBL] [Abstract][Full Text] [Related]
17. Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line.
Poulin R; Baker D; Labrie F
Breast Cancer Res Treat; 1988 Oct; 12(2):213-25. PubMed ID: 3242650
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.
He D; Falany CN
Prostate; 2007 Sep; 67(12):1318-29. PubMed ID: 17626250
[TBL] [Abstract][Full Text] [Related]
19. Binding and effects of 5 alpha-androstane-3 beta,17 beta-diol in the male rat pituitary.
Thieulant ML; Benie T; Michaud S; Klein H; Vessieres A
J Steroid Biochem; 1983 Jul; 19(1A):241-6. PubMed ID: 6887860
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of androgen receptor by progestins and interference with estrogenic or androgenic stimulation of mammary carcinoma cell growth.
Hackenberg R; Hofmann J; Wolff G; Hölzel F; Schulz KD
J Cancer Res Clin Oncol; 1990; 116(5):492-8. PubMed ID: 2229140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
